

Global regulatory affairs and CMC project management expert with over 13 years of experience in leading drug registration programs across multiple markets, including US FDA, EU, Health Canada, Rest of the World markets. Proficient in developing structured, milestone-driven project plans that integrate R&D, quality, manufacturing, supply chain, and commercial stakeholders into a cohesive regulatory strategy. Experienced in lifecycle management of ANDA, MAA, and NDS submissions, health authority query resolution. Bringing disciplined, right-first-time program governance, risk mitigation and cross-functional delivery to fast-paced, matrixed pharmaceutical environments with a natural bridge between R&D science and project execution.